FDA Inspection 1141470 — CellTrans Inc.
The FDA completed an inspection of CellTrans Inc. on May 6, 2021 in Chicago, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 1 citation was issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 6, 2021
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Chicago, IL (United States)
Additional Details
Sponsor, Contract Research Organization
Citations
| ID | CFR | Description |
|---|---|---|
| 7695 | 21 CFR 50.25(c) | ClincialTrials.gov statement |